High materiality7/10
Haemonetics price target raised to $140 from $95 at Mizuho Securities
Why it may matterVerify against the original reporting
Bullish upside potential.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Mizuho raises HAE target to $140; price is $119.38, signaling upside.
- Mizuho raises target to $140; price $119.38.
Key facts
- 01
Target: $140
- 02
Posted price: $119.38
- 03
Analyst firm: Mizuho Securities
- 04
Analyst: Anthony Petrone
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.